Clinical Trials Browser

Phase 2 × Active not recruiting × fedratinib × Clear all

NCT05177211 2025-12-15

Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)

Phase 2 Active not recruiting

MyeloidOther hematologic neoplasm

Myeloproliferative Disorders, Leukemia, Neutrophilic, Chronic